| 2509 |
1948: Upregulation of ACE2 |
1738: SARS-CoV-2 cell entry |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 1238 |
1172: Increased activation, Nuclear factor kappa B (NF-kB) |
1170: Increase, Phenotypic enzyme activity |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2309 |
1172: Increased activation, Nuclear factor kappa B (NF-kB) |
1496: Increased proinflammatory mediators |
Mar 30, 2021 |
Mar 30, 2021 |
3 AOPs
|
| 2431 |
1172: Increased activation, Nuclear factor kappa B (NF-kB) |
87: Release, Cytokine |
Jul 8, 2021 |
Jul 8, 2021 |
1 AOP
|
| 2432 |
1172: Increased activation, Nuclear factor kappa B (NF-kB) |
1493: Increased pro-inflammatory mediators |
Jul 8, 2021 |
Jul 8, 2021 |
1 AOP
|
| 2612 |
1172: Increased activation, Nuclear factor kappa B (NF-kB) |
112: Antagonism, Estrogen receptor |
Mar 22, 2022 |
Aug 27, 2023 |
1 AOP
|
| 1080 |
1039: Increased activity, beta-2 adrenergic receptor |
1040: relaxation, smooth muscle |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2898 |
2128: Increased adipocyte numbers |
2125: Increased fat mass |
May 4, 2023 |
May 4, 2023 |
1 AOP
|
| 2899 |
2127: Increased adipocyte size |
2125: Increased fat mass |
May 4, 2023 |
May 4, 2023 |
1 AOP
|
| 1612 |
1449: increased adipogenesis |
1447: obesity |
Jul 24, 2017 |
Jul 24, 2017 |
1 AOP
|
| 2323 |
1852: Increased Ang II type 1 receptor (AT1R) |
1115: Increase, ROS |
Apr 10, 2021 |
Apr 10, 2021 |
2 AOPs
|
| 2066 |
1752: Increased AngII |
1743: Increase plasma Ang II |
Mar 17, 2020 |
Mar 17, 2020 |
None
|
| 2298 |
1752: Increased AngII |
1849: Impaired gustatory nerve |
Mar 28, 2021 |
Mar 28, 2021 |
None
|
| 2300 |
1752: Increased AngII |
1496: Increased proinflammatory mediators |
Mar 28, 2021 |
Mar 28, 2021 |
None
|
| 2317 |
1752: Increased AngII |
1856: Sodium inhibition, Sweet enhancement |
Apr 10, 2021 |
Apr 10, 2021 |
1 AOP
|
| 2327 |
1752: Increased AngII |
1852: Increased Ang II type 1 receptor (AT1R) |
Apr 10, 2021 |
Apr 10, 2021 |
1 AOP
|
| 2593 |
1752: Increased AngII |
1851: Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R) |
Mar 3, 2022 |
Mar 3, 2022 |
1 AOP
|
| 1647 |
496: Decreased Leydig Cells |
413: Reduction, Testosterone synthesis in Leydig cells |
Aug 11, 2017 |
Aug 11, 2017 |
1 AOP
|
| 2030 |
1722: Increased blood CCK level |
1723: Increased acinar cell exocrine secretion |
Jan 8, 2020 |
Jan 8, 2020 |
1 AOP
|
| 1955 |
1663: brain Homocysteine level increases |
1664: Neuronal dysfunctions induction |
Jun 14, 2019 |
Jun 14, 2019 |
None
|
| 1579 |
1433: Increased CGRP |
1223: Increased Airway Hyper-responsiveness,Cough, Dyspnea |
Jun 23, 2017 |
Jun 23, 2017 |
None
|
| 1580 |
1433: Increased CGRP |
1343: Increase, hypertension |
Jun 23, 2017 |
Jun 23, 2017 |
None
|
| 1586 |
1433: Increased CGRP |
1225: Leukocyte infiltration |
Jun 23, 2017 |
Jun 23, 2017 |
None
|
| 1587 |
1433: Increased CGRP |
1226: Respiratory irritability |
Jun 27, 2017 |
Jun 27, 2017 |
1 AOP
|
| 51 |
39: Increased Cholinergic Signaling |
360: Decrease, Population growth rate |
Nov 29, 2016 |
Dec 3, 2016 |
None
|